Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C18H26FN3O3 |
Molecular Weight | 351.4157 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCOC(=O)C12CCC(CC1)(CC2)NCC(=O)N3C[C@@H](F)C[C@H]3C#N
InChI
InChIKey=AKFNKZFJBFQFAA-DIOPXHOYSA-N
InChI=1S/C18H26FN3O3/c1-2-25-16(24)17-3-6-18(7-4-17,8-5-17)21-11-15(23)22-12-13(19)9-14(22)10-20/h13-14,21H,2-9,11-12H2,1H3/t13-,14-,17?,18?/m0/s1
Bisegliptin (also known as KRP-104) was developed as an orally active dipeptidyl peptidase IV (DPPIV) inhibitor. It is known, that DPPIV inhibition reduces blood glucose through suppression of the degradation of the insulin-releasing hormone. Bisegliptin successfully completed the phase II clinical trials for patients with type 2 diabetes. However, further development of the drug has been discontinued for business reason. The company wasn’t able to find a tie-up partner to co-develop.
Originator
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://clinicaltrials.gov/ct2/show/NCT00995345
Tablet, once-daily for 24 weeks
Route of Administration:
Oral
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
C171768
Created by
admin on Fri Dec 15 19:16:22 GMT 2023 , Edited by admin on Fri Dec 15 19:16:22 GMT 2023
|
PRIMARY | |||
|
100000175105
Created by
admin on Fri Dec 15 19:16:22 GMT 2023 , Edited by admin on Fri Dec 15 19:16:22 GMT 2023
|
PRIMARY | |||
|
862501-61-9
Created by
admin on Fri Dec 15 19:16:22 GMT 2023 , Edited by admin on Fri Dec 15 19:16:22 GMT 2023
|
PRIMARY | |||
|
11688894
Created by
admin on Fri Dec 15 19:16:22 GMT 2023 , Edited by admin on Fri Dec 15 19:16:22 GMT 2023
|
PRIMARY | |||
|
DB06127
Created by
admin on Fri Dec 15 19:16:22 GMT 2023 , Edited by admin on Fri Dec 15 19:16:22 GMT 2023
|
PRIMARY | |||
|
9350
Created by
admin on Fri Dec 15 19:16:22 GMT 2023 , Edited by admin on Fri Dec 15 19:16:22 GMT 2023
|
PRIMARY | |||
|
9U5KQ79OK6
Created by
admin on Fri Dec 15 19:16:22 GMT 2023 , Edited by admin on Fri Dec 15 19:16:22 GMT 2023
|
PRIMARY |
ACTIVE MOIETY